Offices:

Washington DC Office
1101 Pennsylvania Ave.
Suite 600
Washington DC 20004
Telephone: 202-756-2972

Miami Office
1111 Brickell Avenue
11th Floor
Miami, FL 33131
Telephone: 305-913-7199

Fort Lauderdale Office
110 E. Broward Blvd.
Suite 1700
Fort Lauderdale, FL 33301
Telephone: 954-315-3934

Avandia Heart Risks News

FDA Moves to Restrict Access to Three GSK Diabetes Drugs

- Diabetes Heath

06/13/2011 - The U.S. Food and Drug Administration has said that starting on November 18, 2011, it will restrict retail pharmacy sales of three diabetes drugs manufactured by GlaxoSmithKline: the stand-alone Avandia (rosiglitazone) and the combination drugs Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride).

The market restrictions are motivated by the agency's concerns that the drugs increase the risk of heart attacks. To continue taking the drugs, diabetes patients and their prescribers must be enrolled in the Avandia-rosiglitazone Medicines Access Program, a mail-order program run by FDA-certified pharmacies. To enroll, patients will have to show that they cannot successfully control their blood sugar levels with other drugs.

The FDA restriction is the latest in a series of setbacks for what was once the world's best-selling diabetes drug, peaking at $3.2 billion in worldwide sales in 2006. But concerns about subsequent studies, which raised questions about Avandia's effects on bone density and an increased risk of heart attacks, cut deeply into sales. In 2010, sales were $680 million-down almost 80 percent in four years from their high.

The current number of U.S. Avandia users is hard to determine. The FDA's latest figures, from October 2010, showed 119,000 patients filling prescriptions for it, down substantially from 235,500 patients in January 2010.

Glaxo, which is informing U.S. pharmacies now about the November deadline, has advised pharmacists and healthcare providers to caution patients currently taking Avandia not to stop taking it without consulting a medical professional.

Avandia Side Effects Cases Still Being Accepted:

The lawyers of Ennis & Ennis, P.A. are still accepting Avandia side effects cases and have extensive experience representing plaintiffs in Avandia lawsuits nationwide.

If you or a loved one have experienced an Avandia heart attack, or Avandia stroke, Avandia congestive heart failure, Avandia cardiovascular disease or if you have lost a loved one to an Avandia death you may be entitled to compensation. Contact the Avandia lawyers of Ennis & Ennis, P.A. today about an Avandia lawsuit. Call us toll free for a free, confidential case evaluation or fill out our online Avandia case evaluation form

Case Evaluation Form
*Required

Your Full Name:*

E-mail address:*

Mailing address:*

City:*

State:*

Zip:* (5 digit Zip Code)

Phone number:*
(123-123-1234)

Age:*

When did you begin and end using Avandia?

Please list any injuries:

If you have been injured as a result of Avandia side effects we recommend that you notify the FDA
FDA MEDWATCH FORM